Medical Animation Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025
Medical animation is an integral part of any medical technology, as the medical animation can deliver a clear details about medical technology. The development in computer software and hardware with the efforts by various universities have developed a link between science and art, which led to a formation of new generation of information, technology, and designers in biotechnology and drug discovery. The combination of scientific analysis with high end computer graphics and animation capabilities is expected to take the medical sector to the next level of reality. By the use computer technology, the medical animators can create short movies, which could be used in various applications such as, patient education, emergency care education, and drug formula simulation. Individuals involved in the biotechnology research can also use medical animation to explain the wide range of complex research topics.
Promotion through field representatives is the most dependable strategy followed by pharmaceutical and biotechnology companies. However, communication through this channel is not effective as desired, especially for highly potential novel molecules. This can be effectively addressed by medical animation as it allows customer engagement and visual understanding of the product. Medical animation was initially a niche area within the animation and graphics industry. The medical animation market is developing, due to interest of various pharmaceuticals manufacturers, medical organizations, medical device manufacturers, and life sciences research firms. For instance, Amgen, Pfizer, Inc. and Salix Pharmaceuticals are developing a drug delivery animation for patient education.
Adoption of medical animation by pharmaceutical, biopharmaceutical, and medical devices industries is expected to fuel the medical animation market
As the medical and pharmaceutical products are getting more complicated, demand for medical animation is increasing more frequently to explain the function of the products clearly and to emphasize specific values of individual product by animating their complexity and uniqueness. For instance, Random42 scientific communication has worked with 23 top pharmaceutical companies including Abbott, Allergan, Pfizer, Merck, and Janssen for creating medical animation, where the company has also created digital assets for over 550 global pharmaceutical products. Random42 Scientific Communication also launched a new medical animation showreel in March 2017, as the showreel is the selection of Random42’s best medical animation work that were produced over last few year, which is expected to attract the pharmaceutical or medical device manufacturers to the medical animation. The Pediatric Brain Tumor Foundation, with the support of Rubin Postaer and Associates (RPA), a Californian advertising agency, is working to combat childhood cancer with their newly established Imaginary Friend Society, which consists of 20 animated short films that provide comforting and empowering narratives for the children undergoing cancer treatment, in turn supporting the growth of medical animation.
VAYA Pharma’s product Vayarin, a non-drug prescription medical food for the dietary management of ADHD in children, had a niche target audience. In order to attract the target population VAYA Pharma in year 2016, created an animation to explain its prescription medical food, Vayarin, which bosted its product adoption significantly. Such constructive use of the technology can tremendously favor the growth of medical animation market.
Regional growth engines of the medical animation market
On the basis of regional segmentation, the global medical animation market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share followed by Europe and Asia Pacific. Medical animation market in North America is driven by factors, such as increasing number of pharmaceutical companies using animation for product promotion and medical education, and rising penetration of electronic devices such as smartphones. In Asia Pacific, the medical animation market is favored by increasing skills of the company sales representatives, customer engagement activities, and adoption of medical animation for patient education purpose.
The restraining factor for the medical animation market is high cost required for generating medical animation videos and investment in such products. Besides, it requires prior training of the company employees to increase their productivity.
The key players dominating the global medical animation market
The companies are adopting competitive strategies such as new product development, merger & acquisitions and technology upgradation to sustain in the medical animation competitive market. For instance, In July 2017, Random42 was acquired by Graphite Capital, a mid-market private equity firm. Random42, which provides high-quality medical animation and digital media services to the healthcare and pharmaceutical industry is planning to expand geographically in Europe while continuing to grow its North American sales. Investment from graphite capital could help it to meet its objective.
Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1031
The key players operating in the global market of medical animation include Infuse Medical, Hybrid Medical Animation, Inc., Ghost Productions, Inc., Scientific Animations, Inc., INVIVO Communications, Inc., Random42 Scientific Communication, Radius Digital Science, Nucleus Medical Media, Inc., AXS Studio, Inc., Visible Body, Elara Systems, Inc., Animated Biomedical Productions , XVIVO Scientific Animation, Blausen Medical Communications, Inc., Trinsic Medical Animation, LLC., Viscira, and Medmovie Inc.
You may be interested
Rising number of surgical procedures coupled with increasing trauma cases to foster global hemostasis & tissue sealing agents marketAlbert R - May 19, 2018
Hemostasis is a physiological processes, which maintains fluidity of blood by preventing blood loss from body. Hemostasis is characterized by clot formation by activating the natural coagulation…
Synovial Sarcoma Treatment Market Regional InsightsAlbert R - May 19, 2018
Synovial sarcoma consists of abnormal growth of soft-tissue. Synovial sarcoma is a rare type of cancer and is more prevalent in teenagers and young adults. Synovial sarcoma…